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Abstract
Background: Poly(ADP-ribose) (PAR) metabolism participates in several biological processes such as DNA damage
signaling and repair, which is a thoroughly studied function. PAR is synthesized by Poly(ADP-ribose) polymerase
(PARP) and hydrolyzed by Poly(ADP-ribose) glycohydrolase (PARG). In contrast to human and other higher
eukaryotes, Trypanosoma brucei contains only one PARP and PARG. Up to date, the function of these enzymes has
remained elusive in this parasite. The aim of this work is to unravel the role that PAR plays in genotoxic stress
response.
Methods: The optimal conditions for the activity of purified recombinant TbPARP were determined by using a
fluorometric activity assay followed by screening of PARP inhibitors. Sensitivity to a genotoxic agent, H2O2, was
assessed by counting motile parasites over the total number in a Neubauer chamber, in presence of a potent PARP
inhibitor as well as in procyclic transgenic lines which either down-regulate PARP or PARG, or over-express PARP.
Triplicates were carried out for each condition tested and data significance was assessed with two-way Anova
followed by Bonferroni test. Finally, PAR influence was studied in cell death pathways by flow cytometry.
Results: Abolition of a functional PARP either by using potent inhibitors present or in PARP-silenced parasites had
no effect on parasite growth in culture; however, PARP-inhibited and PARP down-regulated parasites presented an
increased resistance against H2O2 treatment when compared to their wild type counterparts. PARP over-expressing
and PARG-silenced parasites displayed polymer accumulation in the nucleus and, as expected, showed diminished
resistance when exposed to the same genotoxic stimulus. Indeed, they suffered a necrotic death pathway, while an
apoptosis-like mechanism was observed in control cultures. Surprisingly, PARP migrated to the nucleus and
synthesized PAR only after a genomic stress in wild type parasites while PARG occurred always in this organelle.
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Conclusions: PARP over-expressing and PARG-silenced cells presented PAR accumulation in the nucleus, even in
absence of oxidative stress. Procyclic death pathway after genotoxic damage depends on basal nuclear PAR. This
evidence demonstrates that the polymer may have a toxic action by itself since the consequences of an exacerbated
PARP activity cannot fully explain the increment in sensitivity observed here. Moreover, the unusual localization of
PARP and PARG would reveal a novel regulatory mechanism, making them invaluable model systems.
Keywords: PARP, PARG, PAR, Trypanosoma brucei, Genotoxic damage, Cell death
Background
Trypanosoma brucei is the etiological agent of the sleeping
sickness in humans and Nagana in cattle, in the region
of Sub-Saharan Africa. According to the World Health
Organization, African trypanosomosis is endemic in 24
African countries, with approximately 30,000 cases in
2010 (WHO, 2010). Current treatments depend on the
stage of the affliction and the disease is typically diag-
nosed only after it has already advanced.
Poly(ADP-ribose)polymerases (PARPs) catalyze the for-
mation of ADP-ribose polymer chains (PAR) by transfer-
ring the ADP-ribose region from NAD+ to certain residues
in target proteins or to a nascent chain (PAR). Most of
these enzymes also typically carry out an auto-modification
reaction. The superfamily of human PARP comprises 17
proteins [1]. Among the functions they carry out, the par-
ticipation of human PARP-1 (hPARP-1) in signalling and
repair of harmed DNA has been the center of most of the
research carried out in the field [2–8].
Poly(ADP-ribose) glycohydrolase (PARG) hydrolyzes
the glycosidic bonds present in the polymer synthesized
by PARP enzymes, re-establishing basal levels of PAR
[3, 4, 9]. One PARG gene is encoded in the human gen-
ome and is expressed as several isoforms which occur in
different cellular organelles [10]. It has been shown that
the depletion of all such isoforms is lethal in embryonic
mice stages [11]. On the other hand, cell-based models ev-
idenced that the lack of PARG isoforms has no conse-
quences on cell viability. However, PARG-deficient cells
failed to amend strand breaks after genomic harm aug-
menting cell death; an outcome that points out the im-
portance of PARG involvement in DNA damage response
[12–14]. Illuzi et al. [15] highlighted that PARG tightly
regulates the polymer levels produced upon genomic
harm, avoiding injurious cell consequences caused by PAR
over-accumulation. Trypanosoma brucei has only one
PARG of 531 amino acids, sharing high sequence identity
and similarity with the orthologous sequence in Trypano-
soma cruzi [16]. To date, no functional studies for PARG
in trypanosomatids have been reported.
Our earlier studies on PAR metabolism in trypanoso-
matids showed that the inhibition of TcPARP negatively
impacts on T. cruzi growth [17]. This result encouraged
us to analyze the only PARP protein identified in T.
brucei (TbPARP). Here we describe the activity require-
ments for the enzyme and identify potent TbPARP in-
hibitors. The most potent compounds were tested in T.
brucei cultures to assess their effect on parasite growth
and their ability to inhibit the polymer synthesis after a
genotoxic stimulus. We have also tested the sensitivity
of PARP over-expressing parasites, as well as PARP or
PARG silenced parasites in oxidative stress conditions.
Furthermore, we determined the cell death pathways in-
volved in every case.
Methods
Protein expression
TbPARP was cloned into a pET-22b + expression vector
[18]. For expression, the pET-22b + vector bearing the
TbPARP gene was transformed to E. coli Rosetta2 (DE3)
strain. Cells were grown in baffled flasks containing
750 mL of Terrific Broth (TB) auto-induction media
with antibiotics (50 μg/mL ampicillin and 34 μg/mL
chloramphenicol), glycerol 8 g/L and trace elements.
Cell pellet was stored at -20 °C in lysis buffer (0.1 M
HEPES pH 7.5, 500 mM Sodium Chloride, 10 % glycerol,
0.01 M imidazole, 500 μM TCEP, 0.05 % IGEPAL).
Protein purification
Lysozyme 0.25 mg, benzonase 250 U (both compounds
from Sigma-Aldrich), a protease inhibitor tablet (Roche),
and 3-AB 1 mM (Alexis Biochemicals) were added to
the thawed cells and samples were sonicated with 50 %
duty cycle for 30 min (BRANSON 250 Sonifier). After
centrifugation, the supernatant was filtered through a
0.45 μm syringe filter. Samples were loaded in HisTrap
HP column (GE Healthcare) and washed with 10 mL of
binding buffer (20 mM HEPES pH 7.5, 0.5 M NaCl,
10 mM imidazole, 10 % glycerol, 500 μM TCEP) using a
peristaltic pump at 4 °C. The column was washed at
room temperature with 25 mM imidazole binding buffer
and eluted with 250 mM imidazole binding buffer. Elute
was divided into four and each sample was further puri-
fied by size exclusion chromatography using a Superdex
200 High Load 10/30 column (GE Healthcare) with bind-
ing buffer. Fractions with higher activity were pooled and
flash frozen as small aliquots to be stored at -70 °C.
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Activity assay optimization
The optimal conditions for the activity of purified re-
combinant TbPARP, were determined by using a fluoro-
metric activity assay [19]. Incubation at 25 °C with
shaking at 300 rpm was placed in propylene plates of 96
wells (Greiner BioOne). To terminate the reaction 2 M
KOH (20 μL) and 20 % acetophenone in ethanol (20 μL)
were added to each well. After incubating for 10 min at
4 °C, 90 μl of 88 % formic acid was added and incubated
in an oven at 110 °C for 5 min. This reaction converts
remaining NAD+ to a fluorescent derivative. After incu-
bation, the plate was allowed to cool down for 15 min
and fluorescence was measured using excitation wave-
lengths of 372 nm and 444 nm for excitation and emis-
sion, respectively (Varioskan Flash 4.00.53, Thermo
Scientific). Consumption of NAD+ was detected by the
decrease in fluorescence. Experiments were done in trip-
licates. The activity in control wells were kept under
25 % by optimizing the protein concentration and the
incubation time, in order to get a robust signal without
slowing down the enzyme activity.
Different assay buffers were tested (Additional file 1)
and the buffering agent was found to have a large impact
on enzymatic activity. The optimal activity was obtained
with phosphate (Na) or phosphate (K) buffer at pH 7.
Importantly, TbPARP activity increases as a function of
nicked DNA (activated DNA) concentration. Maximum
TbPARP activation was achieved at 25 μg/mL (Additional
file 1) causing an 18-fold increase in TbPARP activity. A
small set of cations was also tested in order to verify
whether the enzymatic activity would depend on them.
Most divalent cations resulted in decreased TbPARP activ-
ity, with Ni2+, Mn2+,Ca2+, and Zn2+ showing the greatest
inhibition, while Mg2+, a known co-factor of enzymes that
participate in DNA metabolism, increased TbPARP activ-
ity in vitro 2-fold (Additional file 1). As stabilizing agents
were tested, we observed that the addition of BSA was
beneficial to maintain TbPARP activity when enzyme con-
centration was in nM range. Notably, the addition of both
BSA and Mg2+ showed no increase in TbPARP activity
when compared to the addition of BSA alone and there-
fore Mg2+ was not added in the reaction buffer for fur-
ther experiments. The final assay buffer was 100 mM
Na2HPO4/NaH2PO4 pH 7, 500 μM TCEP, 1 μg/μL BSA,
and 0.025 mg/mL activated DNA (Sigma Aldrich) and
500 nM NAD+ (Sigma Aldrich).
Screening of TbPARP inhibitors
Thirty - one compounds were tested. Dilutions from
DMSO stocks were made (100 μM, 10 μM and 1 μM)
and aliquots of those were used in the enzymatic reac-
tion with 10-fold dilution. Inhibitor solutions were
added in triplicates to the plate, followed by the addition
of the NAD+. Reactions were initiated by addition of
TbPARP diluted in the same buffer (10 nM). The plate
was incubated at 25 °C with shaking (300 rpm, Biosan
PST-100 HL) for 45 min. This resulted in consumption
of 50 % of the NAD+ and signal to background ratio of
2. To detect any potential fluorescence inherent in the
compounds, control reactions were carried out separ-
ately with compound alone at 10 μM final concentration.
The possible fluorescence quenching properties were
controlled using wells within the experimental plate con-
taining the compound with 500 nM NAD+ in the assay
buffer. Wells with only NAD+ present were considered as
100 % inhibition and wells with NAD+ and PARP present
were considered as 0 % inhibition.
Homogenous assay results were confirmed for the
best inhibitors using biotinylated NAD+ as a substrate
(bioNAD+, Trevigen). Incubation mixture consisted of
TbPARP (120 nM), bioNAD+ (1 μM) and nicked DNA
(25 μg/mL) (Sigma Aldrich) in 0.1 M sodium phosphate
buffer (pH 7) at room temperature. The assay was per-
formed in absence (positive control) or in presence of
1 μM inhibitors, after which SDS sample buffer was
added to stop the reaction by heating at 98 °C for 5 min.
TbPARP (120 nM) was also added to the reaction immedi-
ately before stopping it (negative control). PAR-biotinylated
proteins were identified with streptavidin-conjugated
horseradish peroxidase (PerkinElmer) after each reaction
mix was run on SDS-PAGE and transferred onto a mem-
brane of nitrocellulose.
Potency of inhibitors
The half maximal inhibitory concentration (IC50) was
obtained for the most potent TbPARP inhibitors: Veliparib
(ABT-888, Alexis Biochemicals), 4-ANI (Alexis Biochemi-
cals), EB-47 (Alexis Biochemicals), 1,5-Isoquinolinediol
(Alexis Biochemicals), NU1025 (Alexis Biochemicals), PJ-
34 (Alexis Biochemicals), Olaparib (JS Research Chemicals
Trading), RF03876 (Maybridge), and Rucaparib (Selleck
Biochemicals). The IC50 value for 3-AB (Alexis Biochemi-
cals) was also determined to be used as a reference.
Briefly, reaction mix together with the inhibitors at half
log dilutions were added to a 96-well plate (10 data
points). Reactions were incubated for 11 min at 25 °C after
initiating the reaction with the addition of 5 nM TbPARP
at a final volume of 50 μL. Measurement of the remaining
NAD+ is described in section Screening of TbPARP inhibi-
tors. All reactions were performed in triplicates and three
independent dose response curves were fitted for each
inhibitor. Control wells with only NAD+ or NAD+ and
enzyme were used in the curve fitting, as detailed in our
previous work [17].
Structural analysis
TbPARP homologues [UniProt:Q0PW89] were searched
from Protein Data Bank. hPARP-1 [PDB: 3GJW] [20],
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hPARP-2 [PDB:3KJD] [21] and hPARP-3 [PDB:3C4H]
[22] crystal structures were chosen based on homology
and the quality of the structures, and aligned to TbPARP
with ClustalW [23]. Aline [24] was used for the analysis
of the sequence alignment. TbPARP regulatory and cata-
lytic domains were modelled with Modeller [25], based
on hPARP-1 structure. SSM superposition algorithm
implemented in COOT [26, 27] was utilized for struc-
tural superpositions. Structural figures were made with
CCP4mg [28].
Parasite cultures and in culture inhibition of TbPARP
T. brucei procyclic strain 29–13 [29] was cultured at 28 °C
in SDM-79 (Bioscience) containing 10 % (v/v) FCS and
0002 % hemin. T. brucei bloodstream strain 427 90-13
[29] was cultured at 37 °C in HMI-11 (Iscore’s Modified
Dulbecco’s Medium (Invitrogen), 100 mg/L sodium
pyruvate, 136.1 mg/L hypoxantine, 38.7 mg/L thymidine,
28.22 mg/L bathocuproinedisulfonic acid, 181.8 mg/
L L-cysteine, 3.024 mg/L sodium carbonate, 196 μM β-
mercaptoethanol) containing FCS (10 % v/v). Parasite
viability was analyzed by microscopy.
For in culture inhibition assays, parasites of the pro-
cyclic form of Trypanosoma brucei were grown for 48 h
up to a density of 5×106 parasites/mL. Parasites of the
bloodstream form were grown for 24 h up to a density
of 5×105 parasites/mL. In both cases, cells were harvested
and preincubated for 30 min or 10 min in PBS-Glucose
2 % with inhibitors added, after which the parasites were
treated with 500 μM or 250 μM hydrogen peroxide for
procyclic and bloodstream forms, respectively, for 10 min.
Protein extracts were prepared as indicated in our previ-
ous work [17], and 3 μg of total protein were manually
spotted onto a membrane of nitrocellulose (GE Health-
care) for Dot blot analysis revealed with by commercial
PAR antibody (BD).
Effect of the inhibitors on parasite growth
Trypanosoma brucei procyclic parasites were grown in
SDM-79 medium for 48 h until reaching a density of
5×106 cells/mL. Aliquots of 200 μl were distributed in
96-well plates and inhibitors were present at different
final concentrations, as indicated in the figures. Nifurti-
mox (NFX) was used as a positive control in concentra-
tions ranging from 0.25–25 μM. Culture density was
checked by OD600 after 48 h.
Trypanosoma brucei bloodstream parasites were
grown in HMI-11 medium for 24 h until reaching a
density of 5×105 cells/mL. Aliquots of 100 μL were dis-
tributed in 96-well plates and inhibitors were added at
different concentrations as indicated in the figures. After
an incubation period of 24 h, the parasite number was
counted with a Neubauer chamber.
In all experiments, triplicates were done for each condi-
tion tested and data significance was assessed by one-way
Anova (GraphPad Prism5.03 version Software).
PARP and PARG down-regulated T. brucei lines and PARP
over-expressing T. brucei line
A fragment of the TbPARP cDNA (nucleotides 1030 to
1445) [GenBank:DQ679800, Tb927.5.3050] and a frag-
ment of the TbPARG cDNA (nucleotides 593 to 979)
[Tb927.9.12810] were sub-cloned into the tetracycline-
inducible expression vector p2T7TI-177 [30] to down-
regulate the genes of interest. In addition, whole TbPARP
cDNA sequence was sub-cloned into the expression vec-
tor p2216 [31] (PCR primer sequences available upon re-
quest) to over-express the PARP-eYFP fusion gene.
Not I-linearized RNAi-TbPARP and RNAi-TbPARG
constructs and the over-expression construct (10 μg)
were transfected into procyclic parasites by electropor-
ation, as described by Downey et al. [32]. The selection
of the transfectants was carried out with 20 μg/mL zeocin,
and dsRNA and over-expression of the fusion protein was
induced with 1.0 μg/mL tetracycline for 3 days.
Gene expression knock- down was confirmed by
Northern-blot and Western-blot analysis and gene
over-expression was confirmed by Western blot with
specific antibodies.
Effect of hydrogen peroxide (H2O2) in cell survival
Cell survival was determined by incubating 500 μL of 1 ×
106 parasites/mL culture in 24-well cell culture plates
(Cellstar) for 6 h with different concentrations of H2O2
(30 μM, 95 μM, 300 μM and 950 μM) and counting motile
parasites over the total number using a Neubauer cham-
ber. Each condition was tested in triplicates. Statistical
significance was assessed with two-way Anova followed
by Bonferroni test (version 5.03 of GraphPad Prism for
Windows).
Wild type procyclic culture was preincubated for
30 min with Olaparib at 29 nM concentration in order
to measure cell survival, compared to the culture with
no inhibitor added (control). The addition of DMSO in
the same concentration as it is present in Olaparib ex-
periment did not show any difference compared to the
control culture.
Transgenic RNAi-TbPARP (p2T7-TbPARP), RNAi-
TbPARG (p2T7-TbPARG) and TbPARP over-expressing
(p2216-TbPARP) procyclic cultures induced for 3 days
with tetracycline (1 μg/mL) were also challenged with
H2O2 and compared to the non-induced cultures.
Analysis of PAR formation after hydrogen peroxide (H2O2)
treatment by Western blot
Parasites were treated for 10 min with 1 mM H2O2.
Western blot analysis was carried out as it is detailed in
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our previous work [17] with 1:5.000 polyclonal anti-PAR
antibody (BD) made in rabbit. As a loading control we
used α-tubulin antibody.
Immunolocalization of poly(ADP-ribose)
Immunolocalization experiments were carried out as de-
tailed in our previous work [33] with 1:500 polyclonal
anti- PAR antibody (BD) made in rabbit to detect PAR
and 1:100 polyclonal anti-TbPARP antibody (GenScript)
made in rabbit to detect TbPARP. Nuclear and kineto-
plast DNA were stained with DAPI (2 μg/mL) (Sigma).
Nucleus Fluorescence Measurement
Nucleus fluorescence measurement was obtained follow-
ing ImageJ instructions. The area of interest was selected
and parameters such as integrated density, area and mean
grey value were measured by the software. Three different
regions next to the nucleus were also selected as the back-
ground. Finally, corrected nucleus fluorescence was calcu-
lated with the formula: CTCF = Integrated Density - (Area
of selected nucleus × Mean fluorescence of background
readings).
Annexin V flow cytometric analysis
Parasites were treated with 1 mM H2O2 for different
time intervals and the cell death pathway involved was
assessed as it has been detailed in our previous work
[34]. The exposure of wild type procyclic parasites for 6
and 12 h to 10 μg/mL Concanavalin A type IV (Sigma-
Aldrich) confirmed the apoptosis-like death pathway
(positive control) [35, 36]. Transgenic TbPARP over-
expressing (p2216-TbPARP) and RNAi-TbPARG (p2T7-
TbPARG) procyclic cultures were previously induced for
3 days with tetracycline (1 μg/mL). Results were analyzed
with Cyflogic v 1.2.1 software.
Results
In vitro screening of compounds that inhibit TbPARP
Thirty one compounds, most of them previously reported
to inhibit PARP enzymes, were tested to assess their ability
to abrogate TbPARP activity in vitro (Additional file 2:
Table S1) [17]. The compounds were analyzed by the de-
scribed activity assay at concentrations of 1 and 10 μM
(Fig. 1a). DMSO concentration was kept under 1 % in all
experiments described below. Compounds that demon-
strated to have apparent IC50 values higher than 1 μM
Fig. 1 Screening of TbPARP inhibitors. a Inhibition of the in vitro TbPARP (2.5 nM) activity was tested with a library of 31 compounds. Inhibitors
were added at 1 μM (grey bars) or 10 μM (white bars). The values were transformed to % of inhibition. Triplicates were measured for every data
point, and the mean and the standard deviation are shown. b For the most potent inhibitors, % inhibition was determined at 100 nM concentration.
c Inhibition of TbPARP was confirmed in the presence of 1 μM inhibitors by Western blot using 1 μM biotinylated NAD+ as a substrate and in the
presence of activated DNA 25 μg/mL. TbPARP (120 nM) was incubated in the absence of inhibitors for one hour (positive control) or was added
immediately before stopping the reaction (negative control). Synthesized biotinylated PAR was recognized with streptavidin-HRP. Loading of equal
amount of protein in every lane was checked with Lysozyme
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were retested at a lower concentration (100 nM) (Fig. 1b)
and the results were corroborated by Western Blot, in
which inhibitors were added to the reaction at 1 μM con-
centration together with the biotinylated NAD+ substrate
(bioNAD+) (Fig. 1c). Afterwards, IC50 values were experi-
mentally measured for the best inhibitors (Table 1). The
compounds with the most potent inhibiting ability were
Olaparib (IC50 2.9 nM), EB -47 (IC50 6.5 nM), 4-ANI (IC50
23 nM), and Veliparib (IC50 49 nM) (Table 1). These same
inhibitors had previously been demonstrated to be the
most potent inhibitors for the orthologous enzyme in T.
cruzi [17].
Homology modeling and inhibitor selectivity
Inhibitor binding to TbPARP was evaluated by generat-
ing a homology model based on human PARP crystal
structures. Sequence alignment included PARP regula-
tory (REG) and ADP-ribosyl transferase (CAT) domains
as they are conserved in hPARP1-3 and in TbPARP [17].
Importantly, the donor NAD+ binding site is highly con-
served between these proteins. The nicotinamide subsite
(NI) contains the common interactions utilized by many
PARP inhibitors, as the inhibitors form a π-stacking
interaction with Tyr907 and hydrogen bonds to Gly863
and to Ser904 (Fig. 2). This is demonstrated with the
superposition of chicken PARP-1 in complex with 4-
ANI (PDB accession code 2PAX) and TbPARP homology
model. However, there are a few differences between the
REG domains of the hPARP-1 and TbPARP that may
affect the binding of larger inhibitors that extend out of
the NI pocket, such as PJ-34 and Rucaparib, which show
selectivity towards hPARP-1 (Fig. 2).
In culture inhibition of PARP from Trypanosoma brucei
The compounds that were identified as the best inhibitors
of TbPARP in vitro were tested for their effectiveness to
inhibit in culture PAR synthesis on both procyclic and
bloodstream forms of T. brucei. The parasites were chal-
lenged with hydrogen peroxide, a DNA damaging agent
[18, 34]. The inhibitors were tested in culture at a concen-
tration 10-fold higher than the in vitro IC50 value. The
compounds and concentrations were the following:
0.23 μM 4-ANI; 65 nM EB-47; 29 nM Olaparib and1.5 μM
Rucaparib. 3-AB at 580 μM was also tested since it is a
well-known PARP inhibitor. In the case of procyclic para-
sites, Olaparib and Rucaparib inhibited PAR formation in
culture while 4-ANI scarcely inhibited the enzyme and
EB-47 did not inhibit TbPARP at all (Fig. 3a). Most of the
inhibitors diminished, but didn’t inhibit completely PAR
formation in the bloodstream stage of T. brucei at the in-
dicated concentrations (Fig. 3b).
PARP is not essential for T. brucei growth
Olaparib and Rucaparib, which demonstrated to inhibit
PAR formation in culture more effectively than the rest
of the compounds, were selected to be evaluated on
their ability to affect procyclic parasite growth in a series
of concentrations ranging from the in vitro IC50 value
up to two orders of magnitude higher. 3-AB, the inhibi-
tor reported to diminish T. cruzi growth, was also tested.
Nifurtimox was also included in the panel of compounds
as a positive control due to its extensively proven trypa-
nocidal activity [37, 38]. None of the PARP inhibitors
tested were able to negatively affect parasite growth in
culture (Fig. 3c), except for Rucaparib, which caused a
20 % decrease in growth at the highest 15 μM concen-
tration. Nifurtimox, in contrast, slowed down procyclic
parasite growth already at a 2.5 μM concentration.
Growth curves were measured for the bloodstream form
parasites in the presence of Olaparib (29 nM) and
Rucaparib (1.5 μM), and despite that they were able to
inhibit PAR formations in culture they were not able to
significantly affect T. brucei growth or survival (Fig. 3b).
Incubation in the presence of 3-AB or Nifurtimox, how-
ever, did provoke a decrease on bloodstream parasite
growth; although only the effect of 3-AB was significant
when compared to the control (Fig. 3d).
As these results are in contrast with our previous re-
sults on T. cruzi [17], we set out to verify them by
knocking down the enzyme of interest by interference
RNA. The experiments performed with transgenic
RNAi-TbPARP procyclic parasites indeed indicate that
the lack of TbPARP does not alter the culture growing
rate (Additional file 3). Since the protein was not com-
pletely silenced and the low PARP amount remaining
could be enough for survival in regular growth condi-
tions, we evaluated Tet induced RNAi-TbPARP procyclic
parasites in the presence of 290 nM Olaparib. A similar
result was obtained, with no change in growth rate
(Additional file 3). Overall, the experiments suggest that
Table 1 The most potent inhibitors of TbPARP
Compound TbPARP TbPARP hPARP-1 Reference
IC50/μM pIC50 ± SEM IC50 (Ki)/μM
3-AB 58 4.24 ± 0.192 22 [50]
Veliparib 0.049 7.31 ± 0.073 0.005 (Ki) [51]
4-ANI 0.023 7.64 ± 0.198 0.18 [50]
EB-47 0.0065 8.19 ± 0.184 0.045 [52]
1,5-Isoquinolinediol 1.2 5.91 ± 0.072 0.39 [50]
NU1025 0.68 6.17 ± 0.046 0.4 [53]
PJ-34 0.58 6.23 ± 0.109 0.02 [52]
Olaparib 0.0029 8.53 ± 0.104 0.005 [54]
RF03876 1.1 5.94 ± 0.166 - -
Rucaparib 0.15 6.83 ± 0.032 0.0014 (Ki) [55]
Potency values are compared with those reported for human PARP-1. Potency
values are means of the three dose-response curves fitted separately
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TbPARP would not be indispensable for the procyclic
form of T. brucei under standard conditions.
Sensitivity of procyclic Trypanosoma brucei to oxidative
stress
Given that TbPARP is not crucial for the survival of the
procyclic form, we next tried to determine the possible
role of TbPARP in genomic harm signaling and repair
processes. As a parameter of the sensitivity of T. brucei
procyclic parasites to the oxidative stress, we determined
the response to the genotoxic compound hydrogen per-
oxide (H2O2). We estimated the parasite survival by
measuring motility 6 h after the treatment with this
agent in parasites with no functional PARP. Olaparib
was chosen due to its inhibitory potency towards
TbPARP (Table 1). When low doses of hydrogen perox-
ide (30 μM) were used, there was no difference in para-
site viability in presence or absence of Olaparib at a
concentration that has been proven to inhibit effectively
PAR formation in culture (29 nM). However at 95 μM
H2O2, a concentration that diminishes the number of
motile parasites, the presence of Olaparib in the medium
reduced the loss of viability induced by the oxidant and
cultures became more resistant to this genotoxic agent
(Fig. 4a). At a lethal H2O2 concentration (300 μM) there
was a significant decrease in parasite motility both in ab-
sence or presence of Olaparib, however a slight protect-
ive effect could be observed in the presence of this
compound, though not statistically significant. A similar
result could be observed when we compared the effect
of H2O2 on 3 day-induced transgenic RNAi-TbPARP
procyclic cultures to the non-induced ones subjected to
the same treatment (Fig. 4b). Altogether, these experi-
ments demonstrate that the lack of a functional TbPARP
leads to an increase in the resistance against hydrogen
peroxide in procyclic T. brucei parasites.
PARGs are responsible for the break-down of PAR.
We have identified only one protein that belongs to the
PARG family in T. brucei (TbPARG), which expresses in
both stages of the parasite (Additional file 4B). This en-
zyme has an expected molecular weight of 60 kDa.
Moreover, it is always located in the nucleus in procyclic
cultures, independently of the occurrence of genomic
harm (Additional file 4A). This is similar to what we ob-
served earlier for T. cruzi PARG (TcPARG) [33].
In order to test the importance of PAR on the sensitivity
towards oxidative stress we down- regulated PARG ex-
pression by RNAi and also obtained parasites over ex-
pressing TbPARP (Additional file 5 A, B and C). PARG
silencing or increased PARP expression did not cause
morphological alterations but culture growth rate was
slightly diminished in both cases (data not shown). Never-
theless, when we analyzed cell death by FACS, there was
no difference in distribution of population between wild
type, RNAi-TbPARG or PARP over-expressing parasites in
fresh cultures, as it will be shown in the next sections. In a
similar experiment as the one described in Fig. 4a and b,
we analyzed the effect of H2O2 on RNAi-TbPARG and
Fig. 2 Template-based model. Domain organization and homology model of the REG-CAT region of TbPARP, with nicotinamide (NI) and adenosine
(ADE) binding pockets of the substrate NAD+ labelled. The inset shows how 4-ANI binds to the binding site of nicotinamide (built from the chicken
PARP superposition PDB code 2PAX [56]). Residues around the NI site and at the REG domain are shown for TbPARP (grey) and 2PAX (human PARP-1
numbering, blue)
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PARP over-expressing parasites, induced for 3 days. Both
transgenic cells showed increased sensitivity to hydrogen
peroxide treatment, as compared with the control (Fig. 4c,
PARP over-expressing and 4D, PARG silenced parasites).
In the case of the transgenic line over-expressing the
PARP-eYFP fusion protein, we confirmed that this out-
come is specific of an augmented expression of PARP,
since transgenic eYFP over-expressing parasites presented
a milder effect compared to the PARP over-expressing
counterparts (Additional file 6).
Nuclear PAR mediates apoptosis-like to necrosis switch in
severe oxidative stress
Based on these results we decided to examine the conse-
quence of PAR metabolism alteration on H2O2-induced
cell death. We treated parasites with 500 μM H2O2 and,
as shown in Fig. 5a, the amount of PAR in wild type par-
asites increased after 10 min, diminished partially within
the first 90 min and then increased again, probably due
to DNA damage still present in the nucleus. When we
examined the dynamics of PAR synthesis and degrad-
ation in PARP-over expressing or PARG-silenced pro-
cyclic forms of T. brucei, we observed a different pattern
in the amount of PAR 90 and 120 min after a genotoxic
stimulus, compared to wild type cultures (Fig. 5a). Intra-
cellular PAR levels in wild type parasites are usually high
(Fig. 5a 0 min) and located in the cytoplasm (Fig. 5b).
After a genotoxic stimulus, an extensive quantity of PAR
was synthesized in the nucleus and PARP translocated
to this organelle (Fig. 5b and c). PAR signal in the
nucleus was further quantified and it was shown that the
difference between treated and control parasites was
significant. Moreover, it is worth noting that both
TbPARG-silenced and TbPARP-over expressing parasites
showed PAR accumulation in the nucleus even in the
absence of a genotoxic stimulus (Fig. 5d and e, and
Fig. 3 Effect of in culture inhibition of TbPARP on parasite growth. PAR formation was assessed by Dot Blot (a) in procyclic cultures pre-incubated
for 30 min with PARP inhibitors and treated with 500 μM H2O2 for 10 min, and (b) in bloodstream cultures pre-incubated for 10 min with PARP
inhibitors and treated with 250 μM H2O2. Positive controls (H2O2) correspond to those reactions with no inhibitors added, while negative controls
(control) correspond to parasites not treated with H2O2. The membranes were stained with Ponceau Red as a loading control (LC). Lower panels
in both cases show the intensity ratio of PAR to LC signals calculated using ImageJ software. c Effect of the selected PARP inhibitors on procyclic
parasites’ growth after 48 h incubation. d Effect of the selected PARP inhibitors on bloodstream parasites’ growth after 24 h incubation. Nifurtimox
was used at 2.5 μM and inhibitors were used at the same concentrations as in panel B. Culture growth in absence of inhibitors or Nifurtimox was
considered as 100 %. Triplicates were performed for every data point, and expressed as means and standard deviations. Statistical significance is
specified in comparison to control groups (***, P < 0.001; **, P < 0.01; *, P < 0.05)
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Additional file 7). TbPARP-eYFP fusion protein was also
recruited to the nucleus; supporting these results (Fig. 5d,
Additional file 5).
We further investigate the mode in which hydrogen per-
oxide induces cell death in these parasites. Wild type and
transgenic cultures were analyzed for phospholipid redis-
tribution and PI incorporation by flow cytometry. Conca-
navalin A is well known to cause an apoptotic-like death
in T. brucei [35, 36] and control cultures exposed to this
lectin (10 μg/mL) showed the typical apoptosis response
with an increment in Annexin incorporation (Fig. 6b). A
similar pattern to apoptosis control was observed in wild
type cells 6 h after H2O2 injury (Fig. 6c). However, when
cells with modified PAR metabolism were treated, a pat-
tern with an earlier incorporation of PI was obtained in
both transgenic cultures, displaying a necrotic death sig-
nal. It should be taken into account that PARP-over ex-
pressing parasites display an apparent basal apoptosis-like
pattern at time 0 h that is caused by the intrinsic eYFP
fluorescence from the fusion protein; however, the overall
process shows a necrotic-like death pathway (Fig. 6c).
Discussion
Previously, we have demonstrated that T. brucei presents
only one PARP protein (TbPARP) [18]. Here, in an
attempt to describe its enzymatic requirements, we
proved TbPARP is highly activated by damaged DNA, in
agreement with our previous report for the trypanoso-
matids C. fasciculata [39] and T. cruzi [18], and this is
also in-line with the behaviour described for hPARP-1
and 2 [1]. The N-terminus of T. brucei PARP is abun-
dant in basic amino acids and probably the region re-
sponsible for DNA strand break-detection and activity
modulation [18]. TbPARP does not require any metal
ions to carry out its activity. The divalent cations such
as Mn2+, Ni2+or Zn2+ resulted in an inhibitory effect
probably because these ions could bind to important sul-
phydryl groups.
The optimization of the reaction conditions allowed
the use of an activity assay based on the fluorescence
[17, 19] and helped us to identify specific inhibitors to-
wards TbPARP from a library of PARP inhibitors. Simi-
larly to TcPARP, the most potent TbPARP inhibitors
identified were Olaparib, EB-47, 4-ANI, Veliparib, and
Rucaparib. Mostly, the similarities in the IC50 values
among TbPARP, TcPARP, and hPARP-1 can be explained
by the conservation of the donor NAD+ binding pocket,
as evidenced by the homology model (Table 1, Fig. 2).
Rucaparib binds to the nicotinamide binding pocket of
PARPs [40] and lower potency of Rucaparib towards
Fig. 4 Cell survival in cultures with a modified PAR synthesis subjected to hydrogen peroxide (H2O2) treatment. Cell survival was assessed by
measuring parasite motility 6 h after treatment with different H2O2 concentrations. a Procyclic cultures previously incubated with 29 nM Olaparib
for 30 min and with no inhibitor added (control). b Three day-induced (Tet +) and non-induced (Tet -) transgenic RNAi-TbPARP cultures, (c) Three
day-induced (Tet +) and non-induced (Tet -) transgenic TbPARP over- expressing cultures and (d) Three day-induced (Tet +) and non-induced
(Tet -) transgenic RNAi-TbPARG cultures. Three independent experiments were carried out for every case. Statistical significance is specified in
comparison to control groups (***, P < 0.001; **, P < 0.01; *, P < 0.05)
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TbPARP (150 nM) compared to TcPARP (25 nM) [17]
and hPARP-1 (1 nM) can be explained by the amino acid
difference as a conserved alanine is replaced by a serine
(Ser461) in TbPARP, leading to unfavorable interactions.
EB-47 and 4-ANI have been previously reported to in-
hibit PAR synthesis in human cells [41, 42] and pre-
sented 10-fold selectivity for TbPARP over hPARP-1.
However, despite the displayed in vitro enzymatic inhib-
ition they were not able to reduce PAR synthesis in the
parasite. Only Olaparib and Rucaparib were able to re-
duce PAR formation in both procyclic and bloodstream
forms. This might be explained by variations in the cap-
ability of these drugs to penetrate the parasites external
membrane or by other mechanisms that allow metabolic
detoxification of these inhibitors by the parasite [17].
Surprisingly, only Rucaparib at the highest concentration
(15 μM) rendered a visible impact on the growth rate
of procyclic parasites in the conditions tested here.
This concentration was in a range similar to that
exerted by Nifurtimox, a compound that has been re-
cently incorporated as a combination therapy against
Sleeping Sickness [37, 38].
On the other hand, the absence of an active TbPARP
in procyclic parasites has no consequences on viability,
which has also been proved by our RNAi experiments.
This evidence is in agreement with those results reported
by an RNAi target sequencing study [43]. The result
obtained here differs from the one reported for T. cruzi
Fig. 5 PAR response and localization in procyclic cultures subjected to hydrogen peroxide (H2O2) treatment. a Analysis by Western Blot of
poly(ADP-ribose) formation revealed with anti-PAR antibody (BD) after 1 mM H2O2 treatment for 10 min in wild type (WT), PARP over-expressing
(p2216-TbPARP) and RNAi-TbPARG (p2T7-TbPARG) cultures. Data were normalized to anti-α tubulin band (LC) and are shown as the ratio of PAR
to LC signals. Untreated (control) and procyclic cultures exposed to 500 μM H2O2 for 10 min were analyzed for PAR and PARP localization:
(b) PAR was detected with specific polyclonal antibodies (BD) and nuclear PAR signal (arrow) quantification is shown below. The corrected total
nucleus fluorescence (CTCF) was calculated as = Integrated Density - (Mean fluorescence of background readings X Area of selected nucleus). A
Student Test was performed and significance of the nuclear signal in treated versus control parasites is indicated (*** P < 0.001). c TbPARP
localization was detected with specific polyclonal antibodies (GeneScript) in untreated (control) and procyclic cultures exposed to 500 μM H2O2
for 10 min (arrow). d TbPARP-eYFP fusion protein localization was recognized by eYFP fluorescence and PAR localization was recognized with
polyclonal anti-PAR antibody in a 3 day-induced TbPARP over-expressing cultures (p2216-TbPARP). e PAR localization was recognized with
polyclonal anti-PAR antibody in a 3 day-induced RNAi-TbPARG cultures (p2T7-TbPARG). DAPI was used to identify nuclear (N) and kinetoplastid (K)
DNA. White bar represents 10 μm
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epimastigotes in culture where Olaparib at 25 nM concen-
tration led to a 50 % decrease in growth of the parasites
[17], indicating different roles of PARP enzymes in these
trypanosomatids.
PARP down-regulation did not interfere with normal
cell growth but the cytotoxicity induced by H2O2 was re-
duced both by PARP down-regulation and by Olaparib.
Cell death can be achieved through an apoptotic or a
necrotic pathway, which depends on the type of cell and
the concentration of the H2O2 involved. There is evi-
dence that PAR acts as a switch not only between sur-
vival pathways but also between cell death signalling,
mediating a particular cellular response against a specific
DNA damage [2]. This mechanism was described by us
for the trypanosomatid T. cruzi [34] where PARP carries
out a differential function in genomic damage-response.
Despite DNA repair mechanisms are not totally clarified
in these parasites, many pieces of this puzzle are avail-
able in the literature [44, 45]. Here we have demon-
strated that TbPARP is activated under a genotoxic
stimulus and migrates to the nucleus. This phenomenon
of translocation has also been demonstrated in T. cruzi
by our group [34]. An antagonic role can be assigned to
PARP function under stress conditions. When the levels
Fig. 6 Cell death analysis by flow cytometry. a The diagram represents cell subpopulations identified by staining with propidium iodide (PI) and
Annexin V-FITC conjugate. b Wild type culture was treated with 10 μg/mL of Concanavalin A (Con A) as an apoptosis-like control. c Diagram of
wild type (WT), TbPARP over-expressing (p2216-TbPARP) and TbPARG down-regulated (p2T7-TbPARG) procyclic cultures after 1 mM H2O2 treatment for
different time intervals. Transgenic parasites were previously induced for three days
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of genomic harm are low, PARP activation plays a protect-
ive role. Otherwise, substantial genotoxic stimulus induces
loss of viability and cell death. PAR is therefore the mo-
lecular switch between different cell death pathways [8].
In this regard, PARP inhibition could prevent the massive
reduction of NAD+ and thus prevent the energy store de-
pletion [46] that leads to the loss of viability induced by
high doses of H2O2. Our results obtained with Olaparib,
PARP- silenced and PARP over-expressing parasites are in
line with this reasoning.
The real function of PARG regarding cell death is con-
troversial and some authors have reported that PARG in-
hibition provides protection to oxidative-stressed neuronal
cells [47]. Studies based on PARG-silenced cells show con-
flicting results ranging from protection to lack of effect
using different cytotoxic agents [13, 46]. PARG suppres-
sion would lead to PARP inhibition by auto-PARylation.
Although we have demonstrated auto-PARylation in
T. cruzi, this mechanism was not established in T. brucei
yet. On the other hand, cell death is augmented in PARG-
deficient cells which are impaired to repair breaks in one
and both strands, pointing out the PARG critical role in
DNA damage response [12–14]. Although a function for
PARG in regulation of oxidative stress-induced cell death
has not been clarified, alteration of PAR cycle would lead
to a delay in DNA repair and would explain the increased
sensitivity to genotoxic stimuli.
PARP over-expressing and PARG-silenced cells evi-
denced PAR accumulation in the nucleus, even in ab-
sence of oxidative stress. Increased nuclear PAR in
parasites with abrogated PARG demonstrates an active
polymer synthesis in procyclic parasites and indicates
that PARG is the main PAR cycling enzyme. After a
cytotoxic stimulus, both transgenic parasites presented a
different pattern in the PAR levels. Moreover, these para-
sites with an altered PAR metabolism demonstrated an
increased sensitivity towards oxidative stress, and the
changes obtained in the pattern of membrane permeabil-
ity and PI incorporation indicate that PARP and PARG
would mediate apoptosis-like to necrosis death switch.
The duality of PAR being a molecular switch between
both life and cell death has been proposed by many au-
thors. PAR is involved in DNA damage response. How-
ever, an augmented PAR formation could deplete NAD+
and consequently remove ATP from the cell, inducing
cell death. We showed that not only the quantity of the
synthesized PAR might have an effect on parasite sur-
vival, but also its particular nuclear localization. Andrabi
and colleagues described that PAR could be toxic by it-
self studying the effect of the presence of in vitro synthe-
sized PAR delivered inside the cells with a system based
on lipids [48].
Cells die by different mechanisms and this is a subject
of many investigations. Among them, “parthanatos”
happens when hPARP-1 is over activated; and is mainly
related to synthesis of PAR and accumulation, mitochon-
drial depolarization, AIF translocation to the nucleus and
caspases activation; although the latter is not mandatory
[49]. Very little is known about the regulation and the type
of parasite death in trypanosomatids. Moreover, caspases,
calpains and cathepsins, as well as serine proteases and
important mediators such as AIF, have not been identified
yet; making the characterization of different death path-
ways even harder.
Summing up, disrupted PAR metabolism with accumu-
lated polymer in the nucleus has deleterious consequences
to the parasites when exposed to genotoxic stimulus.
Conclusions
Trypanosoma brucei, like Trypanosoma cruzi, has only
one enzyme PARP. However, unlike T. cruzi, protein in-
hibition or the lack of PARP in T. brucei has no conse-
quences on normal replication. This finding shows
substantial dissimilarity regarding PARP role in different
trypanosomatids’ cell cycle.
TbPARP activity seems to be very dynamic, even in
standard conditions. However, after genotoxic stimulus
PAR accumulation in the nucleus is observed. Our results
demonstrate that TbPARP down regulation reduced cyto-
toxicity induced by H2O2; and, accordingly, TbPARP over
expression led to a higher sensitivity against the men-
tioned agent.
PARG, the main PAR hydrolyzing enzyme, has an im-
portant function in maintenance of PAR levels and in
regulation of cell death following a genotoxic insult. Our
results have shown that in undamaged parasites PARG
deficiency does not result lethal; however PAR accumu-
lation in the nucleus conferred an increased sensitivity
towards oxidative stress. In all cases, the presence of
high levels of nuclear PAR constituted a signal leading
to a different cell death pattern. This confirms that the
PAR polymer is cytotoxic by itself.
Overall we have demonstrated the importance of PAR
metabolism in cell death induced by oxidative stress, al-
though further investigation needs to be done to clarify
the mechanisms involved.
Additional files
Additional file 1: Optimization of assay conditions for TbPARP in vitro
activity. NAD+ consumption was measured by a decrease in fluorescence
in a 96-well plate. Triplicates were obtained for every data point, and
expressed as means and standard deviations. A) NAD+ consumption by
TbPARP was measured as a function of pH using a variety of buffering
agents as indicated on the x-axis. B) NAD+ consumption was determined
in 100 mM Na2HPO4/NaH2PO4 buffer at pH 7 at different concentrations
of activated DNA. C) NAD+ consumption by TbPARP (10 nM) was
determined in 100 mM Na2HPO4/NaH2PO4 buffer at pH 7 supplemented
with 25 μg/mL activated DNA in the presence of chloride salts of different
divalent cations (2 mM). (TIF 3064 kb)
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Additional file 2: Table S1: PARP inhibitor like compounds tested.
(XLSX 12 kb)
Additional file 3: Transgenic RNAi-TbPARP procyclic parasites. A)
Representative growth curve shows cell density of tetracycline 3 day-
induced (+Tet) and non-induced (− Tet) RNAi-TbPARP procyclic parasites
of two different clones, 1 and 2, monitored for 11 and 9 days, respectively.
B) Representative growth curve shows cell density of tetracycline 3 day-
induced (+Tet) and non-induced (− Tet) RNAi-TbPARP procyclic parasites in
presence or in absence of 290 nM Olaparib, monitored for 6 days. C) Northern
blot analysis of RNAi-TbPARP procyclic parasites on days 3, 6, 9 and 11
post-induction (p.i.) compared to non-induced cells at identical time
points. 30 μg of total RNA was loaded on every lane. Hybridization was
performed with a [32P]dCTP-labelled TbPARP fragment made by random
priming the same PCR product used as insert in the p2T7-177 vector.
Ribosomal RNA levels confirmed total RNA equal amounts in each lane.
The band corresponding to TbPARP mRNA is shown by an arrow and it
is also present in wild type parasites (WT). D) Western blot analysis of 2
× 106 three day-induced (+ Tet) and non-induced (- Tet) RNAi-TbPARP
cell equivalents revealed with specific 1:100 anti-TbPARP polyclonal
antibody (GeneScript). The membrane stained with Red Ponceau was
used as a loading control. (TIF 888 kb)
Additional file 4: TbPARG in Trypanosoma brucei. A) TbPARG localization
in untreated (control) and in procyclic cultures exposed to 500 μM H2O2
for 10 min. IFI was carried out as reported in our previous work [33].
TbPARG was identified with our home-made antibody against TcPARG
[33]; and PAR was identified with a commercial antibody against PAR
(BD). White bar represents 50 μm. B) Western blot analysis of 40 μg protein
per lane revealed with a commercial anti-PARG antibody (Antibody Verify)
in T. brucei procyclic (PC) and bloodstream (BST) forms. The arrow indicates
the band with the expected molecular weight (approximately 60 kDa).
The membrane stained with Red Ponceau was used as a loading control.
(TIF 4272 kb)
Additional file 5: Transgenic TbPARP over-expressing and TbPARG
down-regulated procyclic parasites. A) Western blot analysis of 3 day-
induced (Tet+) and non-induced (Tet-) TbPARP over-expressing
(p2216-TbPARP-eYFP) parasites. 2 × 106 cell equivalents were revealed
with specific 1:500 mouse monoclonal antibody directed against GFP
(Santa Cruz) (Arrow). Staining of the membrane with Red Ponceau was
used as a loading control. B) Over-expression of TbPARP-eYFP fusion
protein in a 3 day-induced culture (p2216 TbPARP) was also assessed
by IFI, detecting eYFP fluorescence. C) Western blot assessment of
3 day-induced (Tet+) and non-induced (Tet-) RNAi-TbPARG (p2T7 TbPARG)
parasites. 2 × 106 cell equivalents were revealed with commercial 1:500
rabbit antibody directed against PARG proteins (Antibody Verify) (Arrow).
The same membrane revealed with anti-Tubulin antibody was used as a
loading control. (TIF 18,172 kb)
Additional file 6: Cell survival in eYFP over-expressing (p2216) cultures
subjected to hydrogen peroxide (H2O2) treatment. As a control of the
experiment carried out with TbPARP-eYFP over-expressing (p2216-TbPARP)
cultures (Fig. 4c), cell survival of 3 day-induced (Tet+) and non-induced
(Tet -) eYFP over-expressing (p2216) cultures was studied by measuring
parasite motility 6 h after treatment with different hydrogen peroxide
concentrations. Statistical significance of three independent experiments
was assessed in comparison to the control group (* p < 0.05). (TIF 700 kb)
Additional file 7: Nuclear PAR signal quantification in TbPARP-eYFP
over-expressing and TbPARG down-regulated procyclic parasites. PAR and
DAPI (control) fluorescence was measured following ImageJ instructions.
Nuclear area was selected from ten to fifteen parasites and integrated
density (IntDen) was calculated. Three different regions per parasite were
also selected next to the nuclei as a background. CTCF was obtained as
described in Fig. 5b. A and B) TbPARP-eYFP over-expressing parasites.
C and D) RNAi-TbPARG parasites. Student’s Test was performed and
significance of the nuclear signal in (Tet +) versus (Tet -) parasites is
indicated (*** p < 0.001; **, p < 0.01). (TIF 5373 kb)
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